secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGEN CORP (NEOG)
CIK:        0000711377
Form:       8-K
Filed at:   2026-04-09T23:59:59+00:00
Accession:  0001193125-26-148851
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neogen Q3 FY26 revenue $211.2M; net loss $17M; divests Genomics unit
--------------------------------------------------------------------

- Revenue $211.2M; Food Safety core growth +4.0%, Animal Safety core growth –8.7% on supplier challenges.
- GAAP net loss $17.0M ($0.08 loss per share); Adjusted EPS $0.09; Adjusted EBITDA $48.2M (22.8% margin).
- Divestiture of Genomics business announced, expected to close in Q2 FY27; proceeds to reduce leverage.
- Raising FY2026 revenue outlook; maintaining Adjusted EBITDA guidance.
- Petrifilm manufacturing transition on track for November FY27; validation on multiple SKUs started.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711377/000119312526148851/0001193125-26-148851-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711377/000119312526148851/neog-20260409.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-148851

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer